United States · FDA National Drug Code directory
Olanzapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-3276_997c6776-1ac1-bcb1-022c-2c5b6c277395
- Product NDC
- 60505-3276
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Olanzapine
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20111024
- Source listing expiry
- 20261231
Source-listed ingredients
- OLANZAPINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (60505-3276-0) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 60505-3276-0
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (60505-3276-3) · 60505-3276-3
- 1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (60505-3276-8) · 60505-3276-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →